Plain-English translation of NCT06363266 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing TEMPO, a web-based self-management program designed to help men with prostate cancer and their caregivers reduce anxiety and improve their quality of life. TEMPO combines psychosocial support (emotional and mental health tools) and physical activity guidance tailored to each person's needs. The study will compare different ways of delivering the program—some with more guidance from coaches, some more self-directed—to find out which approach works best and is most affordable.
Many men with prostate cancer experience significant anxiety related to their diagnosis, treatment decisions, and side effects—and their caregivers often struggle too. However, there aren't enough healthcare staff to personally guide every patient through self-management strategies. This trial exists to find a sustainable, cost-effective way to deliver online support without requiring intensive one-on-one help from busy clinicians.
You likely qualify if…
You likely don't qualify if…
You and your caregiver would access TEMPO through a secure website, where you'll find tools for managing anxiety, coping with emotions, and staying physically active. Depending on which group you're randomly assigned to, you might use the program entirely on your own, or you might receive regular check-ins and guidance from a non-clinical coach to help keep you motivated. Throughout the study, you'll continue receiving your regular cancer care, and researchers will track your anxiety levels and well-being over time to see which delivery approach works best.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Canada